Home › Funds › Remedium Capital Partners, LLC › ORKA

Remedium Capital Partners, LLC position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Remedium Capital Partners, LLC reported holding 954,150 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$79.5M, representing 29.05% of its reported portfolio and ranking #2 among its reported holdings. Remedium Capital Partners, LLC has disclosed ORKA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)954.15K sh
Reported value held$79.47M
Portfolio Weight29.05%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Remedium Capital Partners, LLC's ORKA position evolved

Remedium Capital Partners, LLC first disclosed a stake in ORKA in Q4 2025 at 1,552,414 shares (US$47.1M). The position peaked in Q2 2026 at 1,565,661 shares, worth US$149.0M. Across 4 filings, Remedium Capital Partners, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 954,150 shares valued at US$79.5M — a reduction of -611,511 shares quarter over quarter.. Notable position changes include a 39% trim in Q3 2026 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.55M $47.05M New
Q1 2026 1.57M $76.80M Add
Q2 2026 1.57M $149.00M Hold
Q3 2026 954.15K $79.47M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 87 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Remedium Capital Partners, LLC held ORKA?

Remedium Capital Partners, LLC has disclosed ORKA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Remedium Capital Partners, LLC's current position in ORKA?

As of Q3 2026, Remedium Capital Partners, LLC holds 954.15K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $79.47M, representing 29.05% of its reported portfolio and ranking #2.

Has Remedium Capital Partners, LLC been buying or selling ORKA?

In the latest 13F filing (Q3 2026), Remedium Capital Partners, LLC reduced its position in ORKA. The position peaked in Q2 2026 at 1.57M shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 87 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.